BCL2L11(1-131)-BRAF(397-766) fusion [cytosol]

Stable Identifier
R-HSA-6802276
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
Literature References
PubMed ID Title Journal Year
25204415 The landscape of kinase fusions in cancer

Kim, JL, Schalm, S, Stransky, N, Lengauer, C, Cerami, E

Nat Commun 2014
External Reference Information
External Reference
Gene Names
BCL2L11, BIM
Chain
chain:1-198
Participates
Other forms of this molecule
Modified Residues
Name
Insertion of residues 397 to 766 at 132 from UniProt:P15056 BRAF
Coordinate
132
Name
O-phospho-L-serine at 446
Coordinate
446
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.
Name
O-phospho-L-serine at 729
Coordinate
729
PsiMod Name
PsiMod Definition
A protein modification that effectively converts an L-serine residue to O-phospho-L-serine.
Disease
Name Identifier Synonyms
thyroid carcinoma DOID:3963 head and neck cancer, Thyroid
cancer DOID:162 malignant tumor, malignant neoplasm, primary cancer
Interactors (22)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:Q07820 MCL1  1 0.948 19
 UniProt:Q07812 BAX  3 0.943 22
 UniProt:Q07817-1 BCL2L1      0.935 10
 UniProt:P10415 BCL2  1 0.926 11
 UniProt:Q92843 B2CL2      0.901 10
 UniProt:Q9HD36 B2L10      0.832 11
 UniProt:Q07817 BCL2L1  2 0.826 11
 UniProt:P97287 MCL1      0.796 7
 UniProt:Q16548 BCL2A1  1 0.683 4
 UniProt:P68451 PG045      0.621 4
 UniProt:Q07440 B2LA1      0.609 2
 UniProt:O43521 BCL2L11  7 0.589 2
 UniProt:Q07813-1 BAX      0.558 7
 UniProt:Q8N6Y0 USBP1      0.556 3
 UniProt:Q13064 MKRN3      0.556 3
 UniProt:Q9UHD9 UBQLN2  1 0.556 3
 UniProt:P43364-2 MAGEA11      0.556 3
 UniProt:Q86UW9 DTX2  1 0.556 3
 UniProt:P40855 PEX19  1 0.556 3
 UniProt:P07237 P4HB  3 0.556 3
 UniProt:P03495 NS1      0.508 2
 UniProt:Q92934 BAD  4 0.499 2
Cite Us!